Trophogen
Trophogen Inc., based in Rockville, MD, is a biotechnology company dedicated to enhancing human and animal health through innovative protein engineering. Their proprietary BioSuperior platform technology focuses on developing long-acting, potent, and safe superagonist analogs of glycoprotein hormones and growth factors, targeting lucrative markets such as infertility and aggressive cancers.
The company has a range of advanced products, including recombinant analogs for bovine and human applications, and has secured significant funding for the development of novel human VEGF analogs aimed at improving targeted imaging of undifferentiated thyroid cancer. Trophogen's licensing agreement with Zoetis Inc. further underscores its commitment to advancing animal health through cutting-edge reproductive solutions.
Generated from the website